BioCardia (BCDA) Return on Equity [ROE] (2009 - 2026)
BioCardia's Return on Equity [ROE] was -904.53% in Q2 2026.
Powered by 
Analysis
BioCardia (BCDA) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at BioCardia came in at -955.89%.
- Return on Equity [ROE] shows a five-year change of -811.91 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -708.06% in FY2023 (-552.15 pp), -155.90% in FY2022 (-70.49 pp) and -85.42% in FY2021 (+58.56 pp).
- Quarterly Return on Equity [ROE] has moved between -2580.10% (Q3 2023) and -87.07% (Q3 2021) over five years.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2024 (a gain of 619.50 percentage points); the worst was Q3 2023 (a drop of 2352.18 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | BioCardia | 11.25 Mn | -1.62 Mn | - | -904.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -904.53% |
| Dec 31, 2025 | -470.07% |
| Sep 30, 2025 | -2,317.41% |
| Dec 31, 2024 | -445.74% |
| Sep 30, 2024 | -1,960.61% |
| Sep 30, 2023 | -2,580.10% |
| Jun 30, 2023 | -737.77% |
| Mar 31, 2023 | -355.83% |
| Dec 31, 2022 | -264.79% |
| Sep 30, 2022 | -227.92% |
| Jun 30, 2022 | -170.02% |
| Mar 31, 2022 | -146.30% |
| Dec 31, 2021 | -106.15% |
| Sep 30, 2021 | -87.07% |
| Jun 30, 2021 | -80.64% |
| Mar 31, 2021 | -73.61% |
| Dec 31, 2020 | -133.33% |
| Sep 30, 2020 | -272.96% |
| Jun 30, 2020 | -501.17% |
| Mar 31, 2020 | -2,804.97% |
API Access
BioCardia Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BCDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BCDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();